ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 218 filers reported holding ZAI LAB LTD in Q1 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,496,540 | -5.3% | 39,393 | -0.4% | 0.10% | -4.5% |
| Q1 2022 | $1,580,000 | -19.6% | 39,543 | 0.0% | 0.11% | -14.7% |
| Q4 2021 | $1,964,000 | -29.5% | 39,543 | 0.0% | 0.13% | -30.3% |
| Q3 2021 | $2,787,000 | -52.0% | 39,543 | +0.4% | 0.18% | -54.8% |
| Q2 2021 | $5,812,000 | -5.4% | 39,393 | 0.0% | 0.41% | -14.3% |
| Q1 2021 | $6,146,000 | -12.5% | 39,393 | 0.0% | 0.48% | -20.1% |
| Q4 2020 | $7,022,000 | +80.1% | 39,393 | 0.0% | 0.60% | +57.1% |
| Q3 2020 | $3,900,000 | +21.8% | 39,393 | 0.0% | 0.38% | +14.5% |
| Q2 2020 | $3,202,000 | -56.8% | 39,393 | -65.7% | 0.33% | -65.5% |
| Q1 2020 | $7,409,000 | +2.7% | 114,893 | -5.0% | 0.96% | +12.9% |
| Q4 2019 | $7,216,000 | +20.5% | 120,893 | -22.0% | 0.85% | +4.0% |
| Q3 2019 | $5,990,000 | +18.4% | 154,893 | 0.0% | 0.82% | +7.5% |
| Q2 2019 | $5,060,000 | +6.5% | 154,893 | -7.3% | 0.76% | +2.8% |
| Q1 2019 | $4,749,000 | -1.6% | 167,173 | -2.8% | 0.74% | -4.5% |
| Q4 2018 | $4,824,000 | – | 171,979 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
| XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
| Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
| Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
| Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
| Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
| BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
| Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
| Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
| Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |